908 Devices (MASS) Gross Margin (2020 - 2026)

908 Devices' (MASS) quarterly Gross Margin came in at 51.43% in Q1 2026, up 438.0% year-on-year from 9.56% in Q1 2025, and down 2.35% on a QoQ basis from 52.67% in Q4 2025.

908 Devices (MASS) Gross Margin (2020 - 2026) Analysis & Trends

908 Devices (MASS) has 7 years of Gross Margin data on file, last reported at 51.43% in Q1 2026.

  • On a quarterly basis, Gross Margin rose 438.0% year-over-year to 51.43% in Q1 2026; TTM through Mar 2026 was 51.49%, a 130.0% increase from a year earlier, with the FY2025 full-year figure at 50.58%, down 74.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 51.43%, down from 52.67% in the prior quarter.
  • Over the last five years, Gross Margin for MASS reached as high as 59.73% in Q2 2022 and fell as low as 46.21% in Q1 2023.
  • Historically, Gross Margin has averaged 51.65% across 5 years, with a median of 51.43% in 2026.
  • Across the five-year window, Gross Margin soared 683 bps in 2022 and plunged 1183 bps in 2023, its largest moves.
  • Year by year, Gross Margin stood at 50.86% in 2022, then decreased by 0 bps to 50.69% in 2023, then dropped by 8 bps to 46.52% in 2024, then climbed by 13 bps to 52.67% in 2025, then retreated by 2 bps to 51.43% in 2026.
  • Per Business Quant data, the three most recent Gross Margin figures were 51.43% in Q1 2026, 52.67% in Q4 2025, and 52.52% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 56.20%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 63.29%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 65.35%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 78.01%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 62.95%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 45.22%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 38.53%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 908 Devices 261.78 Mn 150.04 Mn 6.88 Mn 51.43%

Historic Data

Download Data
DateValue
Mar 31, 2026 51.43%
Dec 31, 2025 52.67%
Sep 30, 2025 52.52%
Jun 30, 2025 48.89%
Mar 31, 2025 47.05%
Dec 31, 2024 46.52%
Sep 30, 2024 53.57%
Jun 30, 2024 53.76%
Mar 31, 2024 52.37%
Dec 31, 2023 50.69%
Sep 30, 2023 55.04%
Jun 30, 2023 47.91%
Mar 31, 2023 46.21%
Dec 31, 2022 50.86%
Sep 30, 2022 59.11%
Jun 30, 2022 59.73%
Mar 31, 2022 49.71%
Dec 31, 2021 57.66%
Sep 30, 2021 54.30%
Jun 30, 2021 52.91%